Synthetic biomimetic coenzymes and alcohol dehydrogenases for asymmetric catalysis
Laia Josa-Culleré (Student TU Delft, University of Oxford)
Antti S.K. Lahdenperä (Student TU Delft, University of Oxford)
Aubert Ribaucourt (Student TU Delft, University of Oxford)
Georg T. Höfler (TU Delft - BT/Biocatalysis)
Serena Gargiulo (Student TU Delft)
Yuan Yang Liu (East China University of Science and Technology)
Francesca Paradisi (University of Nottingham)
Frank Hollmann (TU Delft - BT/Biocatalysis)
Caroline E. Paul (TU Delft - BT/Biocatalysis)
undefined More Authors (External organisation)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Redox reactions catalyzed by highly selective nicotinamide-dependent oxidoreductases are rising to prominence in industry. The cost of nicotinamide adenine dinucleotide coenzymes has led to the use of well-established elaborate regeneration systems and more recently alternative synthetic biomimetic cofactors. These biomimetics are highly attractive to use with ketoreductases for asymmetric catalysis. In this work, we show that the commonly studied cofactor analogue 1-benzyl-1,4-dihydronicotinamide (BNAH) can be used with alcohol dehydrogenases (ADHs) under certain conditions. First, we carried out the rhodium-catalyzed recycling of BNAH with horse liver ADH (HLADH), observing enantioenriched product only with unpurified enzyme. Then, a series of cell-free extracts and purified ketoreductases were screened with BNAH. The use of unpurified enzyme led to product formation, whereas upon dialysis or further purification no product was observed. Several other biomimetics were screened with various ADHs and showed no or very low activity, but also no inhibition. BNAH as a hydride source was shown to directly reduce nicotinamide adenine dinucleotide (NAD) to NADH. A formate dehydrogenase could also mediate the reduction of NAD from BNAH. BNAH was established to show no or very low activity with ADHs and could be used as a hydride donor to recycle NADH.